ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 259 filers reported holding ACCELERON PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $128,574,000 | +17.7% | 747,086 | -14.2% | 0.70% | +13.3% |
| Q2 2021 | $109,204,000 | -2.0% | 870,224 | +5.9% | 0.62% | -11.7% |
| Q1 2021 | $111,466,000 | +16.6% | 821,957 | +10.0% | 0.70% | +15.9% |
| Q4 2020 | $95,631,000 | +6.3% | 747,464 | -6.5% | 0.60% | -11.8% |
| Q3 2020 | $89,978,000 | +117.9% | 799,590 | +84.5% | 0.68% | +89.0% |
| Q2 2020 | $41,286,000 | +32.0% | 433,359 | +24.5% | 0.36% | +7.7% |
| Q1 2020 | $31,288,000 | – | 348,151 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |